Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoIn time for Vision Health Month this May, the Canadian Ophthalmological Society, the national authority on eye and vision care in Canada, has released a new survey to assess Canadians' awareness ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoBEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization
Australian project to 'print' a fix for faulty eye and brain cells
Cosmos· 6 days ago“Imagine a world that we could simply ‘print’ neurological diseases out of existence using bio inks and cheap desktop printers.” Well hello future, or at least one that Matthew Griffith, a biophysicist ...
Is Algae Oil the New Fish Oil?
Men's Health via Yahoo News· 5 days agoAlgae oil is all the rage right now as a vegetarian replace to fish oil. Dietitians explain its health benefits, uses, and risks associated with using...
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks· 3 days agoRegeneron (REGN) reports Q1 results, wherein both the top and bottom lines miss estimates due to lower Eylea sales. Shares down.
SightMD Pennsylvania Expands Practice with Acquisition of James Lewis, MD
PRWeb· 7 days ago/PRNewswire-PRWeb/ -- SightMD Pennsylvania, a leading multi-specialty ophthalmology platform, is pleased to announce the acquisition of James Lewis, MD....
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today
Mizuho Lowers Apellis Pharmaceuticals (NASDAQ:APLS) Price Target to $52.00
ETF DAILY NEWS· 4 days agoApellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) had its target price cut by analysts at Mizuho from $60.00 to $52.00 in a report released on Monday, Benzinga reports. Mizuho’s target ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoFirst quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM(a)(b), revenues increased 7%First quarter 2024 Dupixent® global net sales (recorded by Sanofi) increased 24% to $3.08 billion versus first
Sigma Planning Corp Reduces Stake in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 6 days agoSigma Planning Corp lowered its position in REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 63.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...
